These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14753213)

  • 1. Cost deal for HIV tests.
    Lancet; 2004 Jan; 363(9405):301. PubMed ID: 14753213
    [No Abstract]   [Full Text] [Related]  

  • 2. Prices of CD4 assays and viral load tests must be reduced for developing countries.
    Bartholomew C
    BMJ; 2001 Oct; 323(7316):809-10. PubMed ID: 11588093
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral therapy programmes in resource limited settings.
    del Rio C; Armstrong W
    BMJ; 2011 Nov; 343():d6853. PubMed ID: 22074712
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring treatment: at what cost?
    Cohen J
    Science; 2004 Jun; 304(5679):1936. PubMed ID: 15218140
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 cell count distributions and HIV-associated mortality in Africa.
    Lawn SD; Wood R
    J Infect Dis; 2007 Apr; 195(7):1078-9; author reply 1079. PubMed ID: 17330800
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis.
    Hamers RL; Sawyer AW; Tuohy M; Stevens WS; Rinke de Wit TF; Hill AM;
    AIDS; 2012 Aug; 26(13):1663-72. PubMed ID: 22695297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of HIV treatment in seven countries in the WHO Region of the Americas.
    Belaunzarán-Zamudio PF; Caro-Vega YN; Shepherd BE; Crabtree-Ramírez BE; Luz PM; Grinsztejn B; Cesar C; Cahn P; Cortés C; Wolff M; Pape JW; Padgett D; Gotuzzo E; McGowan C; Sierra-Madero JG;
    Bull World Health Organ; 2015 Aug; 93(8):529-39. PubMed ID: 26478610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.
    Athan E; O'Brien DP; Legood R
    AIDS; 2010 Jul; 24(12):1887-95. PubMed ID: 20543661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senegal cuts deal for low-cost drugs.
    IAPAC Mon; 2001 Jan; 7(1):4. PubMed ID: 11305274
    [No Abstract]   [Full Text] [Related]  

  • 12. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
    Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
    Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snapshot of a pandemic.
    Pilcher H
    Nature; 2004 Jul; 430(6996):134-5. PubMed ID: 15241383
    [No Abstract]   [Full Text] [Related]  

  • 16. Public health. Getting HIV treatment to the most people.
    Lynch S; Ford N; van Cutsem G; Bygrave H; Janssens B; Decroo T; Andrieux-Meyer I; Roberts T; Balkan S; Casas E; Ferreyra C; Bemelmans M; Cohn J; Kahn P; Goemaere E
    Science; 2012 Jul; 337(6092):298-300. PubMed ID: 22798404
    [No Abstract]   [Full Text] [Related]  

  • 17. Low cost diagnostics.
    Huff B
    GMHC Treat Issues; 2001; 15(11-12):1-4. PubMed ID: 11819965
    [No Abstract]   [Full Text] [Related]  

  • 18. A new affordable flow cytometry based method to measure HIV-1 viral load.
    Greve B; Weidner J; Cassens U; Odaibo G; Olaleye D; Sibrowski W; Reichelt D; Nasdala I; Göhde W
    Cytometry A; 2009 Mar; 75(3):199-206. PubMed ID: 19034933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Floodgates of hope" open for HIV-ravaged nations.
    CMAJ; 2003 Mar; 168(6):756. PubMed ID: 12642446
    [No Abstract]   [Full Text] [Related]  

  • 20. Late presentation of HIV/AIDS patients: a Caribbean problem.
    Bartholomew C; Boyce G; Fraser O; Sebro A; Telfer-Baptiste M; Labastide S
    AIDS Patient Care STDS; 2011 Dec; 25(12):707-8. PubMed ID: 21457053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.